Skip to main content
. 2015 Jul;36(7):1277–1282. doi: 10.3174/ajnr.A4275

Table 2:

Imaging characteristics and treatment

Fragmented Thrombus (n = 24) (7.4%) Single Thrombus (n = 300) (92.6%) P
Affected vascular territory .739
    Anterior circulation (No.) (%) 21 (87.5) 267 (89.0)
    Posterior circulation (No.) (%) 3 (12.5) 33 (11.0)
Occlusion site .372
    Tandem occlusion (No.) (%) 3 (12.5) 29 (9.7)
    Carotid-T (No.) (%) 3 (12.5) 14 (4.7)
    MCA M1 (No.) (%) 8 (33.3) 123 (41.0)
    MCA M2 (No.) (%) 6 (25.0) 74 (24.7)
    MCA M3/4 (No.) (%) 1 (4.2) 23 (7.7)
    Anterior cerebral artery (No.) (%) 0 (0.0) 4 (1.3)
    Basilar artery (No.) (%) 3 (12.5) 16 (5.3)
    Posterior cerebral artery (No.) (%) 0 (0.0) 17 (5.7)
Primary thrombus length on SWI (mm) (mean) (SD) 10.3 (6.4) (n = 18) 10.3 (5.6) (n = 248) .699
Total clot length (mm) (mean) (SD) 20.1 (10.7) (n = 18) 10.3 (5.6) (n = 248) <.001
DWI ASPECTS (media) (range) 5 (0–8) (n = 21) 7 (0–10) (n = 263) .006
Leptomeningeal collaterals n = 19 n = 199 .051
    Good (No.) (%) 4 (21.1) 88 (44.2)
    Moderate/poor (No.) (%) 15 (78.9) 111 (55.8)
Treatment .625
    Intravenous thrombolysis only (No.) (%) 6 (25.0) 102 (34.0)
    Bridging thrombolysis (No.) (%) 7 (29.2) 69 (23.0)
    Endovascular intervention only (No.) (%) 11 (45.8) 129 (43.0)